InDex Pharmaceuticals: UC Acquisition – Pinpointing That InDex Trades Far Below Fair Value - Redeye
Redeye leaves a comment on InDex following the recently announced news that Pfizer has acquired Arena Pharmaceuticals for a total equity value of USD 6.7bn. In our view, this deal portrays that the market fails to reflect cobitolimods potential.
ANNONS
Redeye leaves a comment on InDex following the recently announced news that Pfizer has acquired Arena Pharmaceuticals for a total equity value of USD 6.7bn. In our view, this deal portrays that the market fails to reflect cobitolimods potential.